Nuvaring
NDC Package 50090-1008-0

11-digit billing NDC: 50090100800 · Billing unit: EA · 1 EA per package

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nuvaring is fOR VAGINAL USE ONLYNuvaRing® is indicated for use by females of reproductive age to prevent pregnancy. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-1008 and is authorized under FDA application NDA021187.

Identification & Billing

NDC Package Code
50090-1008-0
Package Description
1 POUCH in 1 BOX / 1 d in 1 POUCH
Product Code
11-Digit Billing Format
50090100800
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk
  • RxCUI: 1367436 - etonogestrel 0.12 MG / ethinyl estradiol 0.015 MG per 24HR 3 Week Vaginal System
  • RxCUI: 1367436 - 21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System
  • RxCUI: 1367436 - ethinyl estradiol 0.015 MG / etonogestrel 0.12 MG per 24HR 3 Week Vaginal System
  • RxCUI: 1367436 - ethinyl estradiol 15 MCG / etonogestrel 120 MCG per 24HR 3 Week Vaginal System
  • RxCUI: 1367439 - NuvaRing 0.12 MG / 0.015 MG per 24HR 3 Week Vaginal System

Clinical Specifications

Proprietary Name
Nuvaring
Dosage Form
-
Usage Information
FOR VAGINAL USE ONLYNuvaRing® is indicated for use by females of reproductive age to prevent pregnancy.

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
NDA021187
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-03-2001
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-1008-0 identifies a specific commercial package of 1 pouch in 1 box / 1 d in 1 pouch of Nuvaring, labeled by A-s Medication Solutions. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on October 03, 2001. The current certification is valid through December 31, 2022.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090100800. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-1008-0
11-Digit CMS (5-4-2)
50090-1008-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.